IL123571A - Process for aqueous granulation of a macrolide antibiotic, pharmaceutical granules prepared according to the process and a method for increasing the hardness of such pharmaceutical granules - Google Patents

Process for aqueous granulation of a macrolide antibiotic, pharmaceutical granules prepared according to the process and a method for increasing the hardness of such pharmaceutical granules

Info

Publication number
IL123571A
IL123571A IL12357196A IL12357196A IL123571A IL 123571 A IL123571 A IL 123571A IL 12357196 A IL12357196 A IL 12357196A IL 12357196 A IL12357196 A IL 12357196A IL 123571 A IL123571 A IL 123571A
Authority
IL
Israel
Prior art keywords
pharmaceutical granules
macrolide antibiotic
hardness
increasing
prepared according
Prior art date
Application number
IL12357196A
Other languages
English (en)
Other versions
IL123571A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority claimed from PCT/US1996/016974 external-priority patent/WO1997015286A1/en
Publication of IL123571A0 publication Critical patent/IL123571A0/xx
Publication of IL123571A publication Critical patent/IL123571A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12357196A 1995-11-01 1996-10-18 Process for aqueous granulation of a macrolide antibiotic, pharmaceutical granules prepared according to the process and a method for increasing the hardness of such pharmaceutical granules IL123571A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US715095P 1995-11-01 1995-11-01
US08/722,288 US5919489A (en) 1995-11-01 1996-10-09 Process for aqueous granulation of clarithromycin
PCT/US1996/016974 WO1997015286A1 (en) 1995-10-26 1996-10-23 Method of treating wounds with a gel composition

Publications (2)

Publication Number Publication Date
IL123571A0 IL123571A0 (en) 1998-10-30
IL123571A true IL123571A (en) 2005-07-25

Family

ID=26676595

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12357196A IL123571A (en) 1995-11-01 1996-10-18 Process for aqueous granulation of a macrolide antibiotic, pharmaceutical granules prepared according to the process and a method for increasing the hardness of such pharmaceutical granules

Country Status (13)

Country Link
US (1) US5919489A (de)
EP (1) EP0858324B1 (de)
JP (1) JP4334015B2 (de)
KR (1) KR100524202B1 (de)
AT (1) ATE241963T1 (de)
AU (1) AU706837B2 (de)
CA (1) CA2235607C (de)
DE (1) DE69628575T2 (de)
DK (1) DK0858324T3 (de)
ES (1) ES2200075T3 (de)
IL (1) IL123571A (de)
PT (1) PT858324E (de)
WO (1) WO1997016174A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551616B1 (en) 1997-04-11 2003-04-22 Abbott Laboratories Extended release formulations of erythromycin derivatives
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
IN191239B (de) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
ATE248588T1 (de) * 1999-06-11 2003-09-15 Ranbaxy Lab Ltd Geschmacksmaskierte zubereitungen
AU1169601A (en) * 1999-11-16 2001-05-30 Ranbaxy Laboratories Limited Taste masked oral compositions
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
KR20030047873A (ko) * 2000-02-29 2003-06-18 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물
AU2001263812B2 (en) * 2000-03-28 2004-09-23 Sandoz Ag Granulated particles with masked taste
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
DE10133546A1 (de) * 2001-07-11 2003-03-06 Petra Bastian Mischkomplexe zur Maskierung bitter schmeckender Substanzen
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
ES2323264T3 (es) * 2001-08-01 2009-07-10 Novartis Ag Composicion para enmascaramiento del sabor.
WO2003105810A1 (en) * 2002-06-14 2003-12-24 Andrx Corporation Pharmaceutical compositions for drugs having ph-dependentsolubility
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
EP1417958A1 (de) * 2002-11-08 2004-05-12 Pari GmbH Feuchtgranulierungsverfahren
EP1638529B1 (de) * 2003-06-16 2016-08-10 ANDRX Pharmaceuticals, LLC. Orale zusammensetzung mit verlängerter freisetzung
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
EP1701702A1 (de) * 2003-12-04 2006-09-20 Pfizer Products Inc. Srüh-erstarrungsverfahren mit einem extrudierer zur herstellung von multiteilchenförmigen azitrhomycin-zusammensetzungen, die vorzugsweise ein poloxamer und ein glycerid enthalten
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
ES2600577T3 (es) * 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
RU2268051C2 (ru) * 2003-12-15 2006-01-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
CN1883456B (zh) * 2005-06-20 2010-12-15 常州市第四制药厂有限公司 掩味药物颗粒及其制备方法和用途
JP2009500356A (ja) * 2005-07-07 2009-01-08 エラン ファーマ インターナショナル リミテッド ナノ粒子クラリスロマイシン製剤
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
EP1837020A1 (de) 2006-03-24 2007-09-26 Bioalliance Pharma Bioadhäsive Schleimhautträger zur langsamen Verabreichung von aktiven Substanzen
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
EP2030613A1 (de) 2007-08-17 2009-03-04 Abbott GmbH & Co. KG Herstellung von Zusammensetzungen mit hauptsächlich nichtkristallinen eingebetteten Makrolid-Antibiotika
JP5585920B2 (ja) * 2010-12-27 2014-09-10 富田製薬株式会社 粒子状製剤
CN102813633A (zh) * 2011-06-10 2012-12-12 塔科敏斯基制药厂波尔法合资公司 用湿法制粒制备包含大环内酯类抗生素的药物组合物的方法
RU2692469C1 (ru) * 2018-06-25 2019-06-25 ООО "Новые Антибиотики" Лекарственное средство для лечения и предупреждения возникновения осложнений, связанных с химиотерапией и рентгенотерапией, а также состояний, связанных с повышенной проницаемостью кишки
JP7442193B2 (ja) * 2018-08-10 2024-03-04 日本臓器製薬株式会社 粒状組成物及びその製造方法
CN118511875A (zh) * 2024-05-17 2024-08-20 镇江先锋植保科技有限公司 一种高性能水分散粒剂的制备方法及一种自冷却挤压造粒机

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608278A (en) * 1983-06-22 1986-08-26 The Ohio State University Research Foundation Small particule formation and encapsulation
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions

Also Published As

Publication number Publication date
US5919489A (en) 1999-07-06
MX9803480A (es) 1998-09-30
JPH11514646A (ja) 1999-12-14
EP0858324B1 (de) 2003-06-04
KR100524202B1 (ko) 2006-07-06
EP0858324A1 (de) 1998-08-19
DE69628575D1 (de) 2003-07-10
CA2235607A1 (en) 1997-05-09
WO1997016174A1 (en) 1997-05-09
KR19990067265A (ko) 1999-08-16
CA2235607C (en) 2003-05-13
ES2200075T3 (es) 2004-03-01
PT858324E (pt) 2003-10-31
JP4334015B2 (ja) 2009-09-16
ATE241963T1 (de) 2003-06-15
AU706837B2 (en) 1999-06-24
DK0858324T3 (da) 2003-09-29
AU7517696A (en) 1997-05-22
IL123571A0 (en) 1998-10-30
DE69628575T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
IL123571A (en) Process for aqueous granulation of a macrolide antibiotic, pharmaceutical granules prepared according to the process and a method for increasing the hardness of such pharmaceutical granules
CA2376811A1 (en) Polymer-coated, granulated enzyme-containing feed additives and method for the production thereof
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
PL337126A1 (en) Novel compounds
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
EP0861262A4 (de) Gruppen zum einfangen von nukleinsäuren
AU4712396A (en) Chiral methylphenyloxazolidinones
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
MY125015A (en) Process for the preparation of precipitated calcium carbonates
AU5720498A (en) Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
CA2303202A1 (en) Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
EP0629607A3 (de) Tertiäre Aminogruppen aufweisende Verbindungen, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Katalysatoren.
CA2167693A1 (en) Melanoma-inhibiting protein
HUP9601358A2 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
GB9826540D0 (en) Process
HUP9602640A2 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
AU7302696A (en) An anti-caking agent
AU4876196A (en) A process for the preparation of factor ix from biological sources
WO1998046632A3 (de) Inhibitoren für den urokinaserezeptor
MY132147A (en) Process for the production of enantiomerically- pure- azetidine-2-carboxylic acid
NZ336756A (en) A process for the purification of roxithromycin by crystallisation from methanol
AU5146696A (en) Process for the production of granulated potassium chloride
MY136402A (en) Process for the preparation of precipitated calcium carbonate
EP1354855A3 (de) Verfahren zur Entsalzung von Salzwasser unter Verwendung ionenselektiver Membranen
MX9603342A (es) Piranos-4h-sustituidos.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired